| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.6B | $5.2B | $3.8B | $4.7B | $3.6B | $1.9B | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.9B | $0.6B | $1.0B | $0.8B | $-1.4B | $0.2B | $0.0B |
| EPS (Basic) | $1.05 | $1.69 | $1.11 | $1.84 | $1.56 | $-3.52 | $0.51 | $0.00 |
| EPS (Diluted) | $1.04 | $1.67 | $1.10 | $1.80 | $1.51 | $-3.52 | $0.51 | $0.00 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $53.1B | $46.0B | $35.3B | $32.5B | $39.7B | $33.3B | $44.9B | $31.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.8B | $1.5B | $1.3B | $1.3B | $1.3B | $0.9B | $0.5B | $0.3B |
| Total Liabilities | $43.8B | $38.2B | $28.2B | $25.5B | $33.1B | $27.8B | $37.6B | $25.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $8.4B | $7.8B | $7.0B | $6.9B | $6.6B | $5.3B | $7.2B | $6.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-1.3B | $-2.2B | $1.1B | $6.9B | $2.9B | $1.9B | $-1.6B | $-1.2B |
| Investing Cash Flow | $2.7B | $-2.4B | $0.3B | $0.2B | $2.3B | $8.6B | $-10.9B | $-5.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.5B | $4.8B | $-1.3B | $-7.0B | $-4.7B | $-10.1B | $12.8B | $6.4B |